Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between ...

In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme for the first US Food and Drug Administration-approved injectable HIV ...

October is National Substance Abuse Prevention Month, an opportunity to recognize the impact of substance use in the U.S. and honor the people on the frontlines of the epidemic. This includes local ...

Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year ...

India is in the process of approving lenacapavir, a new HIV prevention drug you only need twice a year—no more daily pills. It's almost 100% effective per dose and costs just $40 a year in low- and ...

A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in decades, has generated mixed ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 countries from 2027, according to Unitaid and the Gates Foundation. The two ...

The Nigerian government has joined global leaders in announcing a historic price reduction for a revolutionary HIV prevention drug, lenacapavir, at the sidelines of the 80th United Nations General ...

The Nigerian Government has reached a landmark agreement for reduction in price of twice-yearly HIV prevention injection, lenacapavir, from 28,000 dollars to just 40 dollars per person on the ...